» Authors » Hana Hakim

Hana Hakim

Explore the profile of Hana Hakim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 566
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hakim H, Richardson T, Riggs R, Auletta J, DiGerolamo K, Hron J, et al.
Hosp Pediatr . 2025 Feb; 15(3):237-246. PMID: 39933563
Objective: Sepsis is associated with significant morbidity and mortality in pediatric hematology, oncology, and transplant (PHOT) patients. This study characterized PHOT patients who developed hospital-onset sepsis more than 12 hours...
2.
Baden L, Swaminathan S, Almyroudis N, Angarone M, Baluch A, Barros N, et al.
J Natl Compr Canc Netw . 2024 Nov; 22(9):617-644. PMID: 39536464
There is an increased risk of infection in patients with cancer that results in higher morbidity and mortality. Several risk factors can predispose these patients to infectious complications. Some such...
3.
Hakim H, Derbel M, Mtibaa H, Akrout B, Trigui K, Chaker F, et al.
Tunis Med . 2024 Oct; 102(10):672-676. PMID: 39441166
Introduction: Vaginal delivery after caesarean section (VBAC) is recommended, but the rising rate of uterine rupture calls into question the safety of this practice. Aim: To identify risk factors for...
4.
Azouz I, Souissi B, Ayadi M, Hakim H, Gassara H, Talbi S, et al.
Radiol Case Rep . 2024 Mar; 19(5):1994-1997. PMID: 38440740
The rupture of the gravid uterus is a rare complication of trauma. It is reported in less than one percent of pregnant women who are victims of road accidents. The...
5.
Hijano D, Dennis S, Hoffman J, Tang L, Hayden R, Gaur A, et al.
Front Public Health . 2024 Jan; 11:1304072. PMID: 38259752
Background: Case investigations and contact tracing are essential disease control measures used by health departments. Early in the pandemic, they were seen as a key strategy to stop COVID-19 spread....
6.
Hijano D, Ferrolino J, Swift E, Michaels C, Max A, Hayden R, et al.
Front Oncol . 2023 Aug; 13:1229655. PMID: 37601666
From 8 December 2021 to 26 January 2023, tixagevimab-cilgavimab (T-C) was authorized for pre-exposure prophylaxis of COVID-19. During this period, we used a multidisciplinary team to communicate, screen, approach, and...
7.
Madni A, Porter A, Crook K, Cartwright C, Hakim H
Pediatrics . 2022 Nov; 150(6). PMID: 36317489
No abstract available.
8.
Johnson S, Billings T, Wittman D, Hakim H
Pediatr Qual Saf . 2022 Oct; 7(Suppl):e603. PMID: 36246155
No abstract available.
9.
Smith J, Sun Y, Hijano D, Hoffman J, Hakim H, Webby R, et al.
BMC Public Health . 2022 Jul; 22(1):1361. PMID: 35840948
Background: COVID-19 has caused over 305 million infections and nearly 5.5 million deaths globally. With complete eradication unlikely, organizations will need to evaluate their risk and the benefits of mitigation...
10.
Swanson H, Hakim H, Hijano D, Morton T, Cross S, Inaba H, et al.
Cancer Med . 2022 Jul; 12(2):1552-1555. PMID: 35837830
Objective: Allergic reactions to pegaspargase during ALL therapy are typically due to antibodies against polyethylene glycol (PEG), which is also used as a stabilizing agent in mRNA-based SARS-CoV-2 vaccines. To...